2025-04-02 23:37:18
Latest Post
Reliance breaks ground on first of 500 CBG plants in Andhra Pradesh
Hindustan Copper Ltd inks agreement for cooperation with Corporacion Nacional Del Cobre De Chile
Authum Investment & Infrastructure Ltd emerges successful resolution applicant for Vas Infrastructure Ltd
Lupin announces the acquisition of Renascience in the United Kingdom
Keel Laying Ceremony of MPV - Yard 21001 for Navi Merchants Denmark
Stock Report
Amrutanjan Health Care Ltd Q2FY2023 PAT climbs QoQ to Rs. 12.76 crores
Posted On : 2022-11-04 22:21:49( TIMEZONE : IST )
Amrutanjan Health Care Limited has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 113.7517 crores during the period ended September 30, 2022 as compared to Rs. 73.9667 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 12.7650 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 3.6640 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 4.36 for the period ended September 30, 2022 as compared to Rs. 1.25 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 113.7517 crs | ₹73.9667 crs |  53.79% |
| Net Profit | ₹12.7650 crs | ₹3.6640 crs | 248.39% |
| EPS | ₹4.36 | ₹1.25 | 248.80% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 113.7517 crores during the period ended September 30, 2022 as compared to Rs.114.6671 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.12.7650 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.19.8478 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.4.36 for the period ended September 30, 2022 as compared to Rs.6.77 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 113.7517 crs | ₹114.6671 crs |  -0.80% |
| Net Profit | ₹12.7650 crs | ₹19.8478 crs | -35.69% |
| EPS | ₹4.36 | ₹6.77 | -35.60% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.187.7184 crores during the 6 Months period ended September 30, 2022 as compared to Rs.195.6175 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.16.4290 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.31.9052 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.5.62 for the 6 Months period ended September 30, 2022 as compared to Rs.10.90 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹187.7184 crs | ₹195.6175 crs | -4.04% |
| Net Profit | ₹16.4290 crs | ₹31.9052 crs | -48.51% |
| EPS | ₹5.62 | ₹10.90 | -48.44% |
Shares of Amrutanjan Health Care Limited was last trading in BSE at Rs. 747.45 as compared to the previous close of Rs. 731.25. The total number of shares traded during the day was 1426 in over 151 trades.
The stock hit an intraday high of Rs. 749.45 and intraday low of 732.00. The net turnover during the day was Rs. 1062157.00.
